AzTrials
AzTrials

Autism Spectrum Disorder (ASD)NCT07597694

Verbal Intent and Gaze Cues on Action Prediction in ASD

An observational study of Autism Spectrum Disorder (ASD) and Intellectual Disability, run by University of Electronic Science and Technology of China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A 2×2×3 mixed design (intent word × object type × group: TD, ASD, ID) was used. Age-matched children watched videos and judged which object a model would pick; their choices and eye movements were recorded. Read more about this study

Who is it for?
Ages 3 to 10 yearsHealthy volunteers can take part
How many people
80 participants
Where
1 siteChina
Study dates
15 Dec 2025to 27 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: A total of 80 children (aged 3-10 years) were initially recruited and divided into three groups: 29 typically developing (TD) children (25 boys, 4 girls) from a kindergarten or primary school in Sichuan Province; 26 children with autism spectrum disorder (ASD) (20 boys, 6 girls) from a local disability federation or autism rehabilitation center in Chengdu, Sichuan Province, all clinically diagnosed and assessed with the Autism Diagnostic Observation Schedule (ADOS); and 25 children with intellectual disability (ID) (14 boys, 11 girls) from a disability federation or rehabilitation center in Chengdu, Sichuan Province, all clinically diagnosed. Based on eye-tracking data, 4 ASD participants and 1 ID participant whose total fixation duration accounted for less than 50% of the total trial time were excluded. Consequently, the final sample included 29 TD children (25 boys, 4 girls), 22 ASD children (18 boys, 4 girls), and 24 ID children (13 boys, 11 girls) for data analysis.

Who may be able to join

  • Children clinically diagnosed with Autism Spectrum Disorder (ASD). Typically developing (TD) children with no developmental or neurological disorders.
  • Children clinically diagnosed with Intellectual Disability (ID).
  • Common criteria for all groups: Normal or corrected-to-normal vision, no color vision deficiencies, normal hearing, and written informed consent provided by their legal guardians.

Who cannot join

  • Failure to meet the study's group-specific screening cutoffs on the Social Responsiveness Scale (SRS) and Social Communication Questionnaire (SCQ).
  • Failure to meet the study's group-specific screening cutoffs on the Autism Diagnostic Observation Schedule (ADOS).
  • Known genetic syndromes, significant hearing loss, or uncorrectable visual impairment.

Trial locations and contacts

1 site in 1 country.

China1 site
  • School of Foreign Languages, University of Electronic Science and Technology of China

    Chengdu, Sichuan, 611731

Other trials in China

About this study

Official title: Exploration of Verbal Intention and Gaze Clues Characteristics in Children With Autism: Based on Eye Tracking Technology

A 2×2×3 mixed design (intent word × object type × group: TD, ASD, ID) was used. Age-matched children watched videos and judged which object a model would pick; their choices and eye movements were recorded.

Read the detailed description

A 2 (intent word: like, dislike) × 2 (object type: mentioned, unmentioned) × 3 (participant group: ASD, TD, ID) mixed experimental design was adopted. Children from the three age-matched groups (29 TD, 22 ASD, 24 ID) completed a video-watching task. In the video, a model was presented with two objects and uttered a sentence containing an intent word, a verb, and a noun, such as "I like to eat oranges." Based on the intent word, trials were divided into "like" and "dislike" conditions. Objects were classified as "mentioned" or "unmentioned" according to the verb and noun used. Participants were required to judge which object the model would pick while watching the video. Their choice responses and eye movements were recorded.

Keywords
Joint Attention, Action Prediction, eye tracking
Medical subject headings
Autism Spectrum Disorder, Intellectual Disability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07597694
Study groupRoleWhat they receive
Autism Spectrum Disorder (ASD) GroupNot described
Typically Developing (TD) GroupNot described
Intellectual Disability(ID)GroupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Total Fixation Duration on Objects

    Percentage of Total Fixation Duration on Objects = (Total time fixating on target objects ÷ Total fixation duration across the scene) × 100%. It measures how much of overall viewing time is spent attending to predefined objects, reflecting attentional priority and object-driven cognitive engagement, normalized for individual differences.

    Measured: During the full 13 seconds video presentation

  2. The time to first fixation on an object within each defined TOI (Time of Interest)

    Time to First Fixation on an Object within a TOI = time elapsed from TOI onset until the first fixation lands on that object. It measures how quickly attention is drawn to a target, reflecting salience or search efficiency. Shorter times indicate faster capture.

    Measured: During the 0-2 s, 2-6 s, and 6-8 s intervals of video

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2026
  2. Study start15 Dec 2025
  3. Primary completion29 Jan 2026
  4. Study completion27 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07597694
Sponsor's protocol ID
UESTC-GazeLab-04
Status last verified
May 2026
First submitted
6 May 2026
Last updated
19 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder (ASD) and Intellectual Disability, run by University of Electronic Science and Technology of China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Total Fixation Duration on Objects (time frame: During the full 13 seconds video presentation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in